跳至主要内容
临床试验/TCTR20230101002
TCTR20230101002尚未招募1 期

Efficacy and safety of Tai Chi for rehabilitation after PCI in patients with coronary heart disease: A protocol of a randomized controlled trial

Huaying Wang0 个研究点目标入组 68 人开始时间: 2023年1月1日最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • (1) Meet the diagnosis of angina pectoris in CHD, and meet coronary angiography or coronary angiography showed at least one coronary artery stenosis and catheter stenosis no less than 50%, cardiac MRI or radionuclide myocardial perfusion imaging confirmed myocardial ischemia and ECG ST-T changes in patients with CHD;
  • (2) Stable condition after surgical treatment with PCI;
  • (3) Aged no less than 18 years, and be not more than 70 years, regardless of gender;
  • (4) limb joint activity is normal, can complete Tai Chi exercise;
  • (5) Patients voluntarily participate in the trial and sign informed consent.

排除标准

  • (1) Patients with severe cardiopulmonary diseases such as dissection of aortic, severe aortic coarctation, aortic aneurysm, pulmonary embolism, pulmonary infarction;
  • (2) Patients with severe cardiac arrhythmia;
  • (3) Patients with severe liver and kidney dysfunction and severe hematopoietic system abnormalities, water electrolyte abnormalities and other diseases;
  • (4) Patients with severe mental illness who have difficulty cooperating;
  • (5) Pregnant or lactating women;
  • (6) Patients with uncontrolled infectious or non-infectious inflammatory diseases;
  • (7) Patients who cannot perform this exercise after professional evaluation;
  • (8) Subjects who are participating in clinical trials of other drugs.

研究者

发起方
Huaying Wang

相似试验